Ansprechen eines BRAFL597Q-mutierten Melanoms auf Trametinib: Zielgerichtete Melanomtherapie jenseits der BRAFV600-Mutationen

Translated title of the contribution: Response of BRAFL597Q-mutant melanoma to trametinib: Targeted melanoma therapy beyond BRAFV600 mutations

O. Haase*, O. Angün, V. Grätz, N. Lüttmann, A. Neumann, D. Zillikens, P. Terheyden

*Corresponding author for this work
2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Response of BRAFL597Q-mutant melanoma to trametinib: Targeted melanoma therapy beyond BRAFV600 mutations'. Together they form a unique fingerprint.

Medicine & Life Sciences